Successfully reported this slideshow.

Introduction of The OIS Index

1

Share

Upcoming SlideShare
Als
Als
Loading in …3
×
1 of 9
1 of 9

Introduction of The OIS Index

1

Share

Download to read offline

Introduction of The OIS Index at OIS@AAO 2016.

Presenter:
Michael Lachman, Founder - EyeQ Research


Powered by:
Healthegy

For more ophthalmology innovation
Visit us at www.ois.net

Introduction of The OIS Index at OIS@AAO 2016.

Presenter:
Michael Lachman, Founder - EyeQ Research


Powered by:
Healthegy

For more ophthalmology innovation
Visit us at www.ois.net

More Related Content

Related Books

Free with a 14 day trial from Scribd

See all

Related Audiobooks

Free with a 14 day trial from Scribd

See all

Introduction of The OIS Index

  1. 1. Introduction: OIS@AAO ■ Chicago ■ October 13, 2016 Michael E. Lachman © Copyright 2016 EyeQ Research and Healthegy/OIS
  2. 2. October 13, 2016 ■ Page 1 Stock Market Indices US Broad Market Indices  Dow Jones Industrial Average  S&P-500  Russell 3000 International Market Indices  Nikkei 225 (Tokyo), FTSE 100 (London), DAX Index (Frankfurt) Market Sector Indices  Dow Jones Transportation and Utility Averages  NASDAQ Biotechnology Index
  3. 3. October 13, 2016 ■ Page 2 Introducing the OIS Index October 1, 2016 1,000.00
  4. 4. October 13, 2016 ■ Page 3 OIS Index Methodology Mid-Cap and Small-Cap Ophthalmic Companies  Publicly Traded  ≥ 50% Ophthalmology  Initial Composition: 70% Biopharma, 30% Ophthalmic Device Market Cap Weighted, with Limits  Largest Companies Capped at 10% of Total Index Value  Others Capped at 8% and 6% Updated and Rebalanced Quarterly  IPOs, Acquisitions, Share Counts  30 - Eleven = 29
  5. 5. October 13, 2016 ■ Page 4 OIS Index Components Mkt. Cap Raw Pct. Adj. Pct. C. Zeiss Meditec $3,091 24% 10.0% Spark Therap. $1,839 14% 8.0% Ophthotech $1,642 13% 8.0% Glaukos $1,246 9.6% 8.0% Aerie Pharma. $1,102 8.5% 8.0% Molecular Part. $529 4.1% 6.0% Omeros $477 3.7% 6.0% STAAR Surgical $380 2.9% 5.8% Clearside Bio. $356 2.8% 5.4% Inotek Pharma. $255 2.0% 3.9% NicOx $231 1.8% 3.5% GenSight Bio. $191 1.5% 2.9% AGTC $177 1.4% 2.7% Ocular Therap. $171 1.3% 2.6% Adverum Bio. $170 1.3% 2.6% Mkt. Cap Raw Pct. Adj. Pct. Second Sight $149 1.2% 2.3% Iridex $147 1.1% 2.2% Thrombogenics $116 0.9% 1.8% pSivida $103 0.8% 1.6% Aldeyra Therap. $98 0.8% 1.5% Alimera Sci. $94 0.7% 1.4% Ohr Pharma. $91 0.7% 1.4% Opthea $84 0.7% 1.3% Presbia $58 0.5% 0.9% Imprimis $50 0.4% 0.8% NovaBay Pharm. $46 0.4% 0.7% TearLab $34 0.3% 0.5% Eyegate Pharm. $16 0.1% 0.3% Escalon Med. $5 .04% .08%
  6. 6. October 13, 2016 ■ Page 5 OIS Index – Six Month Performance April 1 – October 1, 2016 OIS Index +22% Total US Market +6% US Medical Devices + 19% NASDAQ Biotechnology Index + 11% Total US market based on Russell 3000 Index (^RUA) US medical devices based on iShares US Medical Devices ETF (IHI) Equity valuations from MarketXLS
  7. 7. October 13, 2016 ■ Page 6 OIS Index – Key Drivers of Performance April 1 – October 1, 2016 Aerie Pharmaceuticals Glaukos Spark Therapeutics Clearside BioMedical Omeros AGTC Molecular Partners
  8. 8. We Invite Your Feedback… Thank You! Michael E. Lachman ■ michael@EyeQResearch.com Craig Simak ■ craig@healthegy.com © Copyright 2016 EyeQ Research and Healthegy/OIS
  9. 9. October 13, 2016 ■ Page 8

×